Antiva is a California-based biopharmaceutical company that discovers and develops topical therapeutics for the treatment of pre-cancerous lesions caused by HPV infection... Read more
Antiva is a California-based biopharmaceutical company that discovers and develops topical therapeutics for the treatment of pre-cancerous lesions caused by HPV infection... Read more
News
Aug 27, 2025
PR Newswire
Press Release: Antiva Biosciences : Antiva Biosciences Announces Positive Top-Line Results from Phase 1b/2 Study of ABI-2280 for Treatment of Cervical High-Risk Human Papillomavirus (hrHPV) Infection
Jan 01, 2024
StreetInsider
Press Release: Antiva Biosciences : Antiva Biosciences Announces Formation of Scientific and Development Advisory Board
Apr 28, 2023
The Business Journals: San Francisco Business Times
Antiva Biosciences: Biotech veteran Gail Maderis retires on high note as Antiva Biosciences raises $53M to tackle HPV
Apr 27, 2023
FinSMEs
Antiva Biosciences: Antiva Biosciences Closes $53M Series E Equity Financing
Jan 05, 2022
BioSpace
Antiva Biosciences: Antiva Biosciences Named Winner of Global Women's HealthTech Award By World Bank Group and Consumer Technology Association
Nov 03, 2021
The Business Journals
Antiva Biosciences: Biotech raises $31M to take HPV drug into clinical trials
Nov 02, 2021
BioSpace
Antiva Biosciences: Antiva Biosciences Closes $31 Million Series D Equity Financing
Nov 02, 2021
The Business Journals: San Francisco Business Times
Antiva Biosciences: Global vision for women's health lands Peninsula biotech $31M
Nov 09, 2018
The Business Journals
Antiva Biosciences: Antiva Biosciences CEO draws on personal experience to fuel drug development
Oct 07, 2018
BioPortfolio
Antiva Biosciences: Antiva Biosciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250
Antiva Biosciences Competitors
1
2
3
4
5
6
7
8
9
10